Medical Care Technologies (OTC PINK:MDCE) Launches Next-Generation AI Validation Program Targeting Clinical-Grade Accuracy

Rhea-AI Summary

Medical Care Technologies (OTC PINK:MDCE) on October 6, 2025 said it will benchmark an upcoming AI diagnostic model against the HAM10000 public dermatology dataset to validate its image recognition architecture for detecting multiple skin lesion types.

The company said the HAM10000 data will be used under a research license to assess model precision, sensitivity, and specificity relative to peer‑reviewed standards as part of an ongoing proof‑of‑concept development. Management framed this as aligning performance metrics with academic standards and noted risks including data variability, integration challenges, and evolving regulatory guidance.

MESA, AZ / ACCESS Newswire / October 6, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) announced its plan to benchmark its upcoming AI diagnostic model against the HAM10000 public dermatology dataset to validate its image recognition architecture for detecting various skin lesion types.

The benchmarking process will help evaluate model precision, sensitivity, and specificity relative to peer-reviewed standards. The HAM10000 data will be used under its research license as part of MDCE's ongoing proof-of-concept development.

"We are aligning our performance metrics with globally recognized academic standards," said CEO Marshall Perkins III. "This proactive benchmarking approach underscores our focus on building credible, evidence-backed AI systems for healthcare."

Company Website: www.medicalcaretechnologies.com

Safe Harbor Statement:
Forward-looking statements in this communication reflect current expectations and involve risks that may cause actual results to differ. Factors include data variability, integration challenges, and evolving regulatory guidance. The company assumes no obligation to update such statements.

Contact:

Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)

View the original press release on ACCESS Newswire

FAQ

What did MDCE announce on October 6, 2025 about its AI diagnostic model?

MDCE announced it will benchmark its upcoming AI model against the HAM10000 dermatology dataset to validate image recognition for skin lesions.

How will MDCE use the HAM10000 dataset for validation of MDCE stock (MDCE)?

The company will use the HAM10000 dataset under a research license to measure model precision, sensitivity, and specificity versus academic benchmarks.

What performance metrics will MDCE evaluate when testing its AI model?

MDCE said it will evaluate precision, sensitivity, and specificity relative to peer‑reviewed standards.

Does the MDCE announcement include financial results or revenue impact?

No; the announcement focuses on technical benchmarking and proof‑of‑concept work and does not provide financial figures or guidance.

What risks did MDCE cite about its AI benchmarking program?

The company cited risks including data variability, integration challenges, and evolving regulatory guidance.